Back
Marker Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
26
MRKR
Marker Therapeutics
Last Price:
2.88
Seasonality Move:
-21.54%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing slight buying pressure.
Marker Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.81 | Sell |
| 20-day SMA: | 3.18 | Sell |
| 50-day SMA: | 4.01 | Sell |
| 200-day SMA: | 4.23 | Sell |
| 8-day EMA: | 2.86 | Sell |
| 20-day EMA: | 3.14 | Sell |
| 50-day EMA: | 3.66 | Sell |
| 200-day EMA: | 4.07 | Sell |
Marker Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 34.56 | Sell |
| Chaikin Money Flow: | 2145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.87 - 3.61) | Sell |
| Bollinger Bands (100): | (3.37 - 4.91) | Sell |
Marker Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics Stock
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 2.77 while MRKR 8-day simple moving average is 2.81, which is a Sell signal.
- The stock price of MRKR is 2.77 while Marker Therapeutics 20-day SMA is 3.18, which makes it a Sell.
- Marker Therapeutics 50-day simple moving average is 4.01 while MRKR share price is 2.77, making it a Sell technically.
- MRKR stock price is 2.77 and Marker Therapeutics 200-day simple moving average is 4.23, creating a Sell signal.
MRKR Technical Analysis vs Fundamental Analysis
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy or a Sell?
-
Marker Therapeutics stock is rated a Sell
The current Marker Therapeutics [MRKR] share price is $2.77. The Score for MRKR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Marker Therapeutics Stock Info
Market Cap:
24.72M
Price in USD:
2.77
Share Volume:
27.88K
Marker Therapeutics 52-Week Range
52-Week High:
6.16
52-Week Low:
2.40
Sell
26
Marker Therapeutics (MRKR)
is a Sell
Marker Therapeutics Share Price Forecast
-
What is the Marker Therapeutics stock price today?
The Marker Therapeutics stock price is 2.77 USD today. -
Will MRKR stock go up or go down?
Marker Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Marker Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics is overvalued.
Is Marker Therapeutics Stock a Buy?
- Marker Therapeutics share price is 2.77 while MRKR 8-day exponential moving average is 2.86, which is a Sell signal.
- The stock price of MRKR is 2.77 while Marker Therapeutics 20-day EMA is 3.14, which makes it a Sell.
- Marker Therapeutics 50-day exponential moving average is 3.66 while MRKR share price is 2.77, making it a Sell technically.
- MRKR stock price is 2.77 and Marker Therapeutics 200-day simple moving average is 4.07, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics
Is Marker Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Marker Therapeutics
Should I short Marker Therapeutics stock?
- MRKR Moving Average Covergence Divergence (MACD) indicator is -0.33, suggesting Marker Therapeutics is a Sell
- Marker Therapeutics Relative Strength Index (RSI) is 34.56, which suggest Marker Therapeutics is oversold
- The Bollinger Bands (25) for Marker Therapeutics is (2.87 - 3.61), which suggest Marker Therapeutics is a Sell
- The Bollinger Bands (100) for Marker Therapeutics is (3.37 - 4.91), which suggest Marker Therapeutics is a Sell
* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.